XML 89 R72.htm IDEA: XBRL DOCUMENT v3.21.1

Provisions (Tables)

12 Months Ended

Dec. 31, 2020

Provisions (Tables) [Line Items]

Schedule of provisions

		2019				2020
		MCh$				MCh$
Provision for minimum dividends			177,902				138,932
Provisions for contingent loan risks			24,971				98,181
Provisions for other contingencies			501				507
Total			203,374				237,620

Schedule of changes in provision

		Minimum dividends MCh$				Contingent loan risks MCh$				Other MCh$				Total MCh$
Balances as of January 1, 2019			178,462				25,016				468				203,946
Provisions established			177,902				—				33				177,935
Provisions used			(178,462	)			(45	)			—				(178,507	)
Provisions released			—				—				—				—
Balances as of December 31, 2019			177,902				24,971				501				203,374
Balances as of January 1, 2020			177,902				24,971				501				203,374
Provisions established			138,932				73,210				6				212,148
Provisions used			(177,902	)			—				—				(177,902	)
Provisions released			—				—				—				—
Balances as of December 31, 2020			138,932				98,181				507				237,620

Schedule of impairment of losses on contingent loan risks

		Outstanding exposure								ECL
		2019				2020				2019				2020
		MCh$				MCh$				MCh$				MCh$
Warranty by endorsement and sureties			280,838				224,079				63				6,068
Confirmed foreign letters of credit			94,673				58,299				4				10
Issued foreign letters of credit			316,916				343,663				51				235
Performance guarantees			2,283,390				2,214,370				4,037				13,124
Undrawn credit lines			7,870,260				7,650,382				20,816				78,744
Other commitments			155,163				107,707				—				—
Total			11,001,240				10,598,500				24,971				98,181

Schedule of credit quality and the maximum exposure to credit risk

		As of December 31, 2019
		Stage 1								Stage 2								Stage 3
		Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Total MCh$
Normal			94,673				—				—				—				—				—				94,673
Substandard			—				—				—				—				—				—				—
Non—complying			—				—				—				—				—				—				—
Total			94,673				—				—				—				—				—				94,673

		As of December 31, 2020
		Stage 1								Stage 2								Stage 3
		Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Total MCh$
Normal			58,063				236				—				—				—				—				58,299
Substandard			—				—				—				—				—				—				—
Non—complying			—				—				—				—				—				—				—
Total			58,063				236				—				—				—				—				58,299

Warranty by endorsement and sureties [Member]

Provisions (Tables) [Line Items]

Schedule of credit quality and the maximum exposure to credit risk

		As of December 31, 2019
		Stage 1								Stage 2								Stage 3
		Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Total MCh$
Normal			249,306				395				30,761				—				—				—				280,462
Substandard			—				—				376				—				—				—				376
Non—complying			—				—				—				—				—				—				—
Total			249,306				395				31,137				—				—				—				280,838

		As of December 31, 2020
		Stage 1								Stage 2								Stage 3
		Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Total MCh$
Normal			186,051				131				31,911				—				—				—				218,093
Substandard			—				—				356				—				—				—				356
Non—complying			—				—				—				—				5,630				—				5,630
Total			186,051				131				32,267				—				5,630				—				224,079

Schedule of change in gross carrying amount and ECL allowances

		Stage 1								Stage 2								Stage 3
		Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Total MCh$
Outstanding exposure as of January 1, 2019			332,965				138				8,573				—				—				—				341,676
Net change on exposures			(47,268	)			273				7,604				7				—				—				(39,384	)
Transfer to Stage 1			5,243				7				(5,243	)			(7	)			—				—				—
Transfer to Stage 2			(22,454	)			—				22,454				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Foreign exchange adjustments			(19,180	)			(23	)			(2,251	)			—				—				—				(21,454	)
Exposure as of December 31, 2019			249,306				395				31,137				—				—				—				280,838
Outstanding exposure as of January 1, 2020			249,306				395				31,137				—				—				—				280,838
Net change on exposures			(31,759	)			(231	)			(19,038	)			(62	)			—				—				(51,090	)
Transfer to Stage 1			29,099				—				(29,099	)			—				—				—				—
Transfer to Stage 2			(55,270	)			(65	)			55,270				65				—				—				—
Transfer to Stage 3			—				—				(6,069	)			—				6,069				—				—
Foreign exchange adjustments			(5,325	)			32				66				(3	)			(439	)			—				(5,669	)
Exposure as of December 31, 2020			186,051				131				32,267				—				5,630				—				224,079

		Stage 1								Stage 2								Stage 3
		Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Individual MCh$				Group MCh$				Total MCh$
ECL exposures  as of January 1, 2019			428				—				—				—				—				—				428
Net change on exposures			(366	)			—				18				—				—				—				(348	)
Transfer to Stage 1			8				—				(8	)			—				—				—				—
Transfer to Stage 2			(6	)			—				6				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Impact on year-end ECL of exposures transferred between stages during the year			(1	)			—				—				—				—				—				(1	)
Changes to models and assumptions			(32	)			—				7				—				—				—				(25	)
Foreign exchange adjustments			10				—				(1	)			—				—				—				9
ECL as of December 31, 2019			41				—				22				—				—				—				63
ECL exposures  as of January 1, 2020			41				—				22				—				—				—				63
Net change on exposures			(19	)			—				2,838				—				—				—				2,819
Transfer to Stage 1			1				—				(1	)			—				—				—				—
Transfer to Stage 2			(18	)			—				18				—				—				—				—
Transfer to Stage 3			—				—				(3,034	)			—				3,034				—				—
Impact on year-end ECL of exposures transferred between stages during the year			—				—				159				—				2,815				—				2,974
Changes to models and assumptions			167				—				226				—				—				—				393
Foreign exchange adjustments			2				—				36				—				(219	)			—				(181	)
ECL as of December 31, 2020			174				—				264				—				5,630				—				6,068

Confirmed foreign letters of credit [Member]

Provisions (Tables) [Line Items]

Schedule of change in gross carrying amount and ECL allowances

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Outstanding exposure as of January 1, 2019			56,764				—				—				—				—				—				56,764
Net change on exposures			46,648				—				—				—				—				—				46,648
Transfer to Stage 1			—				—				—				—				—				—				—
Transfer to Stage 2			—				—				—				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Foreign exchange adjustments			(8,739	)			—				—				—				—				—				(8,739	)
Exposure as of December 31, 2019			94,673				—				—				—				—				—				94,673
Outstanding exposure as of January 1, 2020			94,673				—				—				—				—				—				94,673
Net change on exposures			(34,528	)			236				—				—				—				—				(34,292	)
Transfer to Stage 1			—				—				—				—				—				—				—
Transfer to Stage 2			—				—				—				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Foreign exchange adjustments			(2,082	)			—				—				—				—				—				(2,082	)
Exposure as of December 31, 2020			58,063				236				—				—				—				—				58,299

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
ECL exposures as of January 1, 2019			29				—				—				—				—				—				29
Net change on exposures			(24	)			—				—				—				—				—				(24	)
Transfer to Stage 1			—				—				—				—				—				—				—
Transfer to Stage 2			—				—				—				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Impact on year-end ECL of exposures transferred between stages during the year			—				—				—				—				—				—				—
Changes to models and assumptions			(1	)																							(1	)
Foreign exchange adjustments			—				—				—				—				—				—				—
ECL as of December 31, 2019			4				—				—				—				—				—				4
ECL exposures as of January 1, 2020			4				—				—				—				—				—				4
Net change on exposures			—				—				—				—				—				—				—
Transfer to Stage 1			—				—				—				—				—				—				—
Transfer to Stage 2			—				—				—				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Impact on year-end ECL of exposures transferred between stages during the year			—				—				—				—				—				—				—
Changes to models and assumptions			7				—				—				—				—				—				7
Foreign exchange adjustments			(1	)			—				—				—				—				—				(1	)
ECL as of December 31, 2020			10				—				—				—				—				—				10

Issued foreign letters of credit [Member]

Provisions (Tables) [Line Items]

Schedule of credit quality and the maximum exposure to credit risk

		As of December 31, 2019
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			149,753				1,308				165,538				317				—				—				316,916
Substandard			—				—				—				—				—				—				—
Non-complying			—				—				—				—				—				—				—
Total			149,753				1,308				165,538				317				—				—				316,916

		As of December 31, 2020
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			298,841				1,881				42,927				—				—				—				343,649
Substandard			—				—				14				—				—				—				14
Non-complying			—				—				—				—				—				—				—
Total			298,841				1,881				42,941				—				—				—				343,663

Schedule of change in gross carrying amount and ECL allowances

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Outstanding exposure as of January 1, 2019			344,874				1,585				41,823				114				—				—				388,396
Net change on exposures			(41,247	)			(362	)			(21,391	)			371				—				—				(62,629	)
Transfer to Stage 1			20,794				491				(20,794	)			(491	)			—				—				—
Transfer to Stage 2			(167,024	)			(333	)			167,024				333				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Foreign exchange adjustments			(7,644	)			(73	)			(1,124	)			(10	)			—				—				(8,851	)
Exposure as of December 31, 2019			149,753				1,308				165,538				317				—				—				316,916
Outstanding exposure as of January 1, 2020			149,753				1,308				165,538				317				—				—				316,916
Net change on exposures			53,462				830				(20,836	)			(530	)			—				—				32,926
Transfer to Stage 1			136,838				866				(136,838	)			(866	)			—				—				—
Transfer to Stage 2			(37,319	)			(1,048	)			37,319				1,048				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Foreign exchange adjustments			(3,893	)			(75	)			(2,242	)			31				—				—				(6,179	)
Exposure as of December 31, 2020			298,841				1,881				42,941				—				—				—				343,663

Undrawn credit lines [Member]

Provisions (Tables) [Line Items]

Schedule of change in gross carrying amount and ECL allowances

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
ECL exposures  as of January 1, 2019			83				10				—				—				—				—				93
Net change on exposures			(61	)			(8	)			10				18				—				—				(41	)
Transfer to Stage 1			—				—				—				—				—				—				—
Transfer to Stage 2			(3	)			(1	)			3				1				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Impact on year-end ECL of exposures transferred between stages during the year			—				—				(2	)			—				—				—				(2	)
Changes to models and assumptions			1				—				—				—				—				—				1
Foreign exchange adjustments			—				—				—				—				—				—				—
ECL as of December 31, 2019			20				1				11				19				—				—				51
ECL exposures  as of January 1, 2020			20				1				11				19				—				—				51
Net change on exposures			7				3				(13	)			(19	)			(1	)			—				(23	)
Transfer to Stage 1			2				—				(2	)			—				—				—				—
Transfer to Stage 2			(10	)			(4	)			10				4				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Impact on year-end ECL of exposures transferred between stages during the year			1				—				10				(4	)			—				—				7
Changes to models and assumptions			111				—				92				—				1				—				204
Foreign exchange adjustments			(2	)			—				(2	)			—				—				—				(4	)
ECL as of December 31, 2020			129				—				106				—				—				—				235

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Outstanding exposure as of January 1, 2019			1,279,611				5,512,504				178,586				786,663				328				11,633				7,769,325
Net change on exposures			(182,381	)			668,090				(50,111	)			(96,818	)			(204	)			(8,651	)			329,925
Transfer to Stage 1			162,455				1,058,685				(162,453	)			(1,058,572	)			(2	)			(113	)			—
Transfer to Stage 2			(118,673	)			(593,536	)			118,848				598,413				(175	)			(4,877	)			—
Transfer to Stage 3			(57	)			(1,970	)			(365	)			(9,938	)			422				11,908				—
Foreign exchange adjustments			(5,837	)			(209,625	)			(1,047	)			(12,102	)			(10	)			(369	)			(228,990	)
Exposure as of December 31, 2019			1,135,118				6,434,148				83,458				207,646				359				9,531				7,870,260
Outstanding exposure as of January 1, 2020			1,135,118				6,434,148				83,458				207,646				359				9,531				7,870,260
Net change on exposures			(28,109	)			20,484				11,628				(102,141	)			(568	)			(7,903	)			(106,609	)
Transfer to Stage 1			80,990				516,008				(80,990	)			(515,854	)			—				(154	)			—
Transfer to Stage 2			(129,707	)			(597,956	)			129,751				606,469				(44	)			(8,513	)			—
Transfer to Stage 3			(183	)			(18,407	)			(949	)			(14,838	)			1,132				33,245				—
Foreign exchange adjustments			(2,990	)			(109,946	)			(570	)			1,530				(22	)			(1,271	)			(113,269	)
Exposure as of December 31, 2020			1,055,119				6,244,331				142,328				182,812				857				24,935				7,650,382

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
ECL exposures  as of January 1, 2019			1,634				9,123				137				4,194				—				5,298				20,386
Net change on exposures			(1,229	)			4,832				25				(1,245	)			63				(848	)			1,598
Transfer to Stage 1			88				6,162				(87	)			(6,141	)			(1	)			(21	)			—
Transfer to Stage 2			(113	)			(6,056	)			191				7,838				(78	)			(1,782	)			—
Transfer to Stage 3			—				(149	)			(12	)			(792	)			12				941				—
Impact on year-end ECL of exposures transferred between stages during the year			(35	)			(389	)			(129	)			(1,116	)			83				1,006				(580	)
Changes to models and assumptions			(112	)			(269	)			63				(28	)			—				—				(346	)
Foreign exchange adjustments			1				(119	)			(3	)			(66	)			(1	)			(54	)			(242	)
ECL as of December 31, 2019			234				13,135				185				2,644				78				4,540				20,816
ECL exposures  as of January 1, 2020			234				13,135				185				2,644				78				4,540				20,816
Net change on exposures			181				(1,726	)			502				(1,262	)			(174	)			(1,004	)			(3,483	)
Transfer to Stage 1			19				7,348				(19	)			(7,301	)			—				(47	)			—
Transfer to Stage 2			(93	)			(5,942	)			101				9,664				(8	)			(3,722	)			—
Transfer to Stage 3			—				(317	)			(67	)			(766	)			67				1,083				—
Impact on year-end ECL of exposures transferred between stages during the year			(1	)			(293	)			77				(1,035	)			349				8,479				7,576
Changes to models and assumptions			899				53,001				267				1,294				116				(1,429	)			54,148
Foreign exchange adjustments			(3	)			(128	)			(8	)			30				(8	)			(196	)			(313	)
ECL as of December 31, 2020			1,236				65,078				1,038				3,268				420				7,704				78,744

Performance Guarantees Contingent Liability [Member]

Provisions (Tables) [Line Items]

Schedule of credit quality and the maximum exposure to credit risk

		As of December 31, 2019
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			1,804,374				44,325				414,621				10,970				—				—				2,274,290
Substandard			—				—				5,806				—				—				—				5,806
Non—complying			—				—				—				—				2,194				1,100				3,294
Total			1,804,374				44,325				420,427				10,970				2,194				1,100				2,283,390

		As of December 31, 2020
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			1,573,058				46,523				568,005				615				—				—				2,188,201
Substandard			—				—				21,833				—				—				—				21,833
Non—complying			—				—				—				—				3,851				485				4,336
Total			1,573,058				46,523				589,838				615				3,851				485				2,214,370

Performance guarantees [Member]

Provisions (Tables) [Line Items]

Schedule of change in gross carrying amount and ECL allowances

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Outstanding exposure as of January 1, 2019			1,685,980				54,523				485,075				3,544				2,310				1,250				2,232,682
Net change on exposures			129,463				(10,568	)			(38,887	)			8,898				(2,950	)			(1,203	)			84,753
Transfer to Stage 1			249,755				18,249				(249,755	)			(18,092	)			—				(157	)			—
Transfer to Stage 2			(229,813	)			(17,111	)			230,906				17,417				(1,093	)			(306	)			—
Transfer to Stage 3			(74	)			(729	)			(3,884	)			(792	)			3,958				1,521				—
Foreign exchange adjustments			(30,937	)			(39	)			(3,028	)			(5	)			(31	)			(5	)			(34,045	)
Exposure as of December 31, 2019			1,804,374				44,325				420,427				10,970				2,194				1,100				2,283,390
Outstanding exposure as of January 1, 2020			1,804,374				44,325				420,427				10,970				2,194				1,100				2,283,390
Net change on exposures			(33,951	)			(8,832	)			(6,254	)			1,305				(5,241	)			(1,226	)			(54,199	)
Transfer to Stage 1			128,944				29,217				(128,944	)			(29,180	)			—				(37	)			—
Transfer to Stage 2			(314,572	)			(17,839	)			314,683				18,347				(111	)			(508	)			—
Transfer to Stage 3			(459	)			(326	)			(6,511	)			(826	)			6,970				1,152				—
Foreign exchange adjustments			(11,278	)			(22	)			(3,563	)			(1	)			39				4				(14,821	)
Exposure as of December 31, 2020			1,573,058				46,523				589,838				615				3,851				485				2,214,370

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
ECL exposures  as of January 1, 2019			2,308				509				765				—				495				3				4,080
Net change on exposures			(1,717	)			(178	)			767				789				(791	)			471				(659	)
Transfer to Stage 1			287				20				(287	)			(20	)			—				—				—
Transfer to Stage 2			(249	)			(233	)			919				233				(670	)			—				—
Transfer to Stage 3			(2	)			(22	)			(192	)			(17	)			194				39				—
Impact on year-end ECL of exposures transferred between stages during the year			(18	)			182				(684	)			(231	)			1,263				(39	)			473
Changes to models and assumptions			(15	)			—				152				—				—				—				137
Foreign exchange adjustments			7				(1	)			—				—				—				—				6
ECL as of December 31, 2019			601				277				1,440				754				491				474				4,037
ECL exposures  as of January 1, 2020			601				277				1,440				754				491				474				4,037
Net change on exposures			359				(160	)			6,341				(674	)			(8,647	)			(454	)			(3,235	)
Transfer to Stage 1			48				78				(48	)			(68	)			—				(10	)			—
Transfer to Stage 2			(222	)			(169	)			237				179				(15	)			(10	)			—
Transfer to Stage 3			—				(2	)			(4,038	)			(6	)			4,038				8				—
Impact on year-end ECL of exposures transferred between stages during the year			2				235				362				(172	)			6,261				(8	)			6,680
Changes to models and assumptions			2,002				658				2,138				(10	)			851				—				5,639
Foreign exchange adjustments			—				—				(10	)			—				13				—				3
ECL as of December 31, 2020			2,790				917				6,422				3				2,992				—				13,124

Undrawn Credit Lines Contingent Liabilities [Member]

Provisions (Tables) [Line Items]

Schedule of credit quality and the maximum exposure to credit risk

		As of December 31, 2019
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			1,135,118				6,434,148				81,990				207,646				—				—				7,858,902
Substandard			—				—				1,468				—				—				—				1,468
Non—complying			—				—				—				—				359				9,531				9,890
Total			1,135,118				6,434,148				83,458				207,646				359				9,531				7,870,260

		As of December 31, 2020
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			1,055,119				6,244,331				138,432				182,812				20				—				7,620,714
Substandard			—				—				3,896				—				—				—				3,896
Non—complying			—				—				—				—				837				24,935				25,772
Total			1,055,119				6,244,331				142,328				182,812				857				24,935				7,650,382

Other commitments [Member]

Provisions (Tables) [Line Items]

Schedule of credit quality and the maximum exposure to credit risk

		As of December 31, 2019
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			155,163				—				—				—				—				—				155,163
Substandard			—				—				—				—				—				—				—
Non—complying			—				—				—				—				—				—				—
Total			155,163				—				—				—				—				—				155,163

		As of December 31, 2020
		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Normal			107,707				—				—				—				—				—				107,707
Substandard			—				—				—				—				—				—				—
Non—complying			—				—				—				—				—				—				—
Total			107,707				—				—				—				—				—				107,707

Schedule of change in gross carrying amount and ECL allowances

		Stage 1								Stage 2								Stage 3
		Individual				Group				Individual					Group			Individual				Group				Total
		MCh$				MCh$				MCh$				MCh$				MCh$				MCh$				MCh$
Outstanding exposure as of January 1, 2019			46,561				—				—				—				—				—				46,561
Net change on exposures			108,602				—				—				—				—				—				108,602
Transfer to Stage 1			—				—				—				—				—				—				—
Transfer to Stage 2			—				—				—				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Foreign exchange adjustments			—				—				—				—				—				—				—
Exposure as of December 31, 2019			155,163				—				—				—				—				—				155,163
Outstanding exposure as of January 1, 2020			155,163				—				—				—				—				—				155,163
Net change on exposures			(47,456	)			—				—				—				—				—				(47,456	)
Transfer to Stage 1			—				—				—				—				—				—				—
Transfer to Stage 2			—				—				—				—				—				—				—
Transfer to Stage 3			—				—				—				—				—				—				—
Foreign exchange adjustments			—				—				—				—				—				—				—
Exposure as of December 31, 2020			107,707				—				—				—				—				—				107,707

Stage 1

Stage 2

Stage 3

Individual

Group

Individual

Group

Individual

Group

Total

MCh$

MCh$

MCh$

MCh$

MCh$

MCh$

MCh$

ECL exposures as of January 1, 2019

—

—

—

—

—

—

—

Net change on exposures

—

—

—

—

—

—

—

Transfer to Stage 1

—

—

—

—

—

—

—

Transfer to Stage 2

—

—

—

—

—

—

—

Transfer to Stage 3

—

—

—

—

—

—

—

Impact on year-end ECL of exposures transferred between stages during the year

—

—

—

—

—

—

—

Changes to models and assumptions

—

—

—

—

—

—

—

Foreign exchange adjustments

—

—

—

—

—

—

—

ECL as of December 31, 2019

—

—

—

—

—

—

—

ECL exposures as of January 1, 2020

—

—

—

—

—

—

—

Net change on exposures

—

—

—

—

—

—

—

Transfer to Stage 1

—

—

—

—

—

—

—

Transfer to Stage 2

—

—

—

—

—

—

—

Transfer to Stage 3

—

—

—

—

—

—

—

Impact on year-end ECL of exposures transferred between stages during the year

—

—

—

—

—

—

—

Changes to models and assumptions

—

—

—

—

—

—

—

Foreign exchange adjustments

—

—

—

—

—

—

—

ECL as of December 31, 2020

—

—

—

—

—

—

—

X

- Definition

Disclosure of information pertaining to changes in provisions.

+ References

No definition available.

+ Details

Name:	bch_DisclosureOfChangesInProvisionsTableTextBlock
Namespace Prefix:	bch_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	bch_ProvisionsTablesLineItems
Namespace Prefix:	bch_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of credit quality and the maximum exposure to credit risk based on the Bank's internal credit rating system and year-end stage classification .

+ References

No definition available.

+ Details

Name:	bch_ScheduleOfCreditQualityAndMaximumExposureToCreditRiskTableTextBlock
Namespace Prefix:	bch_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of impairment of losses.

+ References

No definition available.

+ Details

Name:	bch_ScheduleOfImpairmentLosses
Namespace Prefix:	bch_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of investment entities. An investment entity is an entity that: (a) obtains funds from one or more investors for the purpose of providing those investor(s) with investment management services; (b) commits to its investor(s) that its business purpose is to invest funds solely for returns from capital appreciation, investment income, or both; and (c) measures and evaluates the performance of substantially all of its investments on a fair value basis.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2020-01-01
-Section Investment entity status
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2020-en-r&doctype=Standard&dita_xref=IFRS12_g9A-9B_TI
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfInvestmentEntitiesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of provisions. [Refer: Provisions]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2020-01-01
-Paragraph 10
-Subparagraph e
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfProvisionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the reconciliation of changes in the loss allowance and explanation of changes in the gross carrying amount for financial instruments. Loss allowance is the allowance for expected credit losses on financial assets measured in accordance with paragraph 4.1.2 of IFRS 9, lease receivables and contract assets, the accumulated impairment amount for financial assets measured in accordance with paragraph 4.1.2A of IFRS 9 and the provision for expected credit losses on loan commitments and financial guarantee contracts. [Refer: Gross carrying amount [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2020-01-01
-Paragraph 35H
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_35H&doctype=Standard
-URIDate 2020-01-01

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2020-01-01
-Paragraph 35I
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2020-en-r&anchor=para_35I&doctype=Standard
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_WarrantyByEndorsementAndSuretiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_ConfirmedForeignLettersOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_IssuedForeignLettersOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_UndrawnCreditLinesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_PerformanceGuaranteesContingentLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_PerformanceGuaranteesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_UndrawnCreditLinesContingentLiabilitiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ClassesOfContingentLiabilitiesAxis=bch_OtherCommitmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: